Indoleamine-2,3-dioxygenase-related anti-inflammatory effects of 3-aminobenzamide and infliximab in experimental colitis.

Ebru Menekşe Sezai Aydin Oğuz Uğur Aydın Duygu Sahin Gülçin Akça Abdullah Eroğlu Aylin Sepinci Dincel Yesim Ozkan Mete Dolapci

Published in: Revista da Associacao Medica Brasileira (1992) (2022)

Altered expression of indoleamine-2,3-dioxygenase results in a lower bacterial translocation via infliximab compared with 3-aminobenzamide treatment. Combined treatments emphasized different approaches for the new molecules related to indoleamine-2,3-dioxygenase.

Keyphrases

ulcerative colitis
anti inflammatory
poor prognosis
long non coding rna
drug induced
combination therapy